ClassID:

109145

C12N2310/14 - page 24 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#6901
20120264675
2012-10-18

CMV gene products promote cancer stem cell growth

#6902
20120263740
2012-10-18

APTAMER-TARGETED SIRNA TO INHIBIT NONSENSE MEDIATED DECAY

#6903
20120263738
2012-10-18

MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES

#6904
20120259150
2012-10-11

Compositions and Methods of Sphingosine Kinase Inhibitors In Radiation Therapy of Various Cancers

#6905
20120259001
2012-10-11

Duplex oligonucleotides with enhanced functionality in gene regulation

#6906
20120258889
2012-10-11

siRNA targeting kinase insert domain receptor (KDR)

#6907
20120258888
2012-10-11

siRNA Targeting Proto-oncogene MET

#6908
20120258646
2012-10-11

Compositions for controlling mites in bees

#6909
20120258535
2012-10-11

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#6910
20120258534
2012-10-11

METHOD OF DELIVERING RNA INTERFERENCE AND USES THEREOF

#6911
20120258495
2012-10-11

Sequence diversity generation in immunoglobulins

#6912
20120258116
2012-10-11

Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration

#6913
20120258104
2012-10-11

Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes

#6914
20120255045
2012-10-04

Inducible small RNA expression constructs for targeted gene silencing

#6915
20120255042
2012-10-04

Method of regulating gene expression

#6916
20120253032
2012-10-04

NOVEL CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR OLIGONUCLEOTIDE DELIVERY

#6917
20120252875
2012-10-04

Methods and compositions for treating diseases, disorders or injury of the CNS

#6918
20120252874
2012-10-04

Methods for delivery of siRNA to the spinal cord and therapies arising therefrom

#6919
20120252873
2012-10-04

siRNA Targeting Interleukin-1 Receptor-associated Kinase 4 (IRAK4)

#6920
20120252872
2012-10-04

RNAi modulation of APOB and uses thereof

#6921
20120252869
2012-10-04

TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)

#6922
20120252737
2012-10-04

Methods for Diagnosing and Treating Cancer

#6923
20120252027
2012-10-04

Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications

#6924
20120252011
2012-10-04

Composition for treatment of pancreatic cancer

#6925
20120251560
2012-10-04

Conjugated lipomers and uses thereof

#6926
20120251499
2012-10-04

Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single CpG site in TTP promoter and treatment of cancers by regulating its epigenetic status

#6927
20120246747
2012-09-27

RNA-INTERFERENCE BY SINGLE-STRANDED RNA MOLECULES

#6928
20120245217
2012-09-27

RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

#6929
20120245076
2012-09-27

COMPOSITIONS AND METHODS FOR DELIVERING RNAI USING APOE

#6930
20120245045
2012-09-27

Methods and kits to identify invasive glioblastoma

#6931
20120244618
2012-09-27

Methods and systems for identifying micro-RNA targets and synthesizing novel micro-RNAs and uses of the same

#6932
20120244613
2012-09-27

Human microRNAs and methods for inhibiting same

#6933
20120244210
2012-09-27

COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE

#6934
20120244207
2012-09-27

Methods for increasing efficacy of lipid formulated siRNA

#6935
20120244170
2012-09-27

TREATING CANCER BY MODULATING MEX-3

#6936
20120244077
2012-09-27

METHODS AND COMPOSITIONS FOR MAINTENANCE OF A FUNCTIONAL WOUND

#6937
20120238937
2012-09-20

Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)

#6938
20120238022
2012-09-20

INDUCIBLE SYSTEMS AND METHODS FOR CONTROLLING siRNA EXPRESSION

#6939
20120238017
2012-09-20

NOVEL SIRNA STRUCTURE FOR MINIMIZING OFF-TARGET EFFECTS AND RELAXING SATURATION OF RNAI MACHINERY AND THE USE THEREOF

#6940
20120237589
2012-09-20

AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS

#6941
20120237499
2012-09-20

Methods of identifying modulators of TDP-43 mediated cellular toxicity

#6942
20120232260
2012-09-13

Amphiphilic nucleotide cochleate compositions and methods of using the same

#6943
20120232128
2012-09-13

Treatment of influenza

#6944
20120232127
2012-09-13

REGULATION OF NEUROTRANSMITTER RELEASE THROUGH ANION CHANNELS

#6945
20120232126
2012-09-13

Multi-targets interfering RNA molecules and their applications

#6946
20120231007
2012-09-13

MODULATORS OF CELL CYCLE PROGRESSION

#6947
20120231002
2012-09-13

Treatment of vasculoproliferative conditions with Lrg1 anatgonists

#6948
20120230991
2012-09-13

METHODS AND COMPOUNDS FOR ENHANCING ANTI-CANCER THERAPY

#6949
20120230959
2012-09-13

Enhancement of placental stem cell potency using modulatory RNA molecules

#6950
20120230942
2012-09-13

Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders

#6951
20120230938
2012-09-13

Polyconjugates for in vivo delivery of polynucleotides

#6952
20120227119
2012-09-06

Methods of Modulating the Sex of Avians

#6953
20120225928
2012-09-06

Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes

#6954
20120225927
2012-09-06

Compositions and methods for inhibiting expression of transthyretin

#6955
20120225477
2012-09-06

Viral and viral associated mirnas and uses thereof

#6956
20120225434
2012-09-06

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#6957
20120225129
2012-09-06

CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

#6958
20120225115
2012-09-06

Methods and compositions for improved deliver, expression or activity of RNA interference agents

#6959
20120225088
2012-09-06

Compositions and methods for treating cancer and other diseases

#6960
20120225082
2012-09-06

ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis

#6961
20120225076
2012-09-06

FRA-1 TARGET GENES AS DRUG TARGETS FOR TREATING CANCER

#6962
20120225034
2012-09-06

AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#6963
20120222139
2012-08-30

Cancer Specific Mitotic Network

#6964
20120220649
2012-08-30

MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE

#6965
20120220496
2012-08-30

siRNA targeting catenin, Beat-1 (CTNNB1)

#6966
20120220033
2012-08-30

INHIBITION OF VIRAL GENE EXPRESSION USING SMALL INTERFERING RNA

#6967
20120214865
2012-08-23

Methods for slowing familial ALS disease progression

#6968
20120214861
2012-08-23

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#6969
20120214703
2012-08-23

Methods for Diagnosing Stomach Cancer Using MicroRNA Signatures

#6970
20120214702
2012-08-23

Methods for Diagnosing Prostate Cancer Using MicroRNA Signatures

#6971
20120214701
2012-08-23

Methods for diagnosing lung cancer using MicroRNA signatures

#6972
20120214700
2012-08-23

Methods for diagnosing colon cancer using MicroRNA signatures

#6973
20120214699
2012-08-23

Methods for Diagnosing Breast Cancer Using MicroRNA Signatures

#6974
20120214698
2012-08-23

Methods for diagnosing stomach cancer using MicroRNAs

#6975
20120214697
2012-08-23

Methods for diagnosing prostate cancer using MicroRNAs

#6976
20120214696
2012-08-23

Methods for diagnosing pancreatic cancer using MicroRNAs

#6977
20120214695
2012-08-23

Methods for diagnosing lung cancer using microRNAs

#6978
20120214694
2012-08-23

Methods for diagnosing colon cancer using MicroRNAs

#6979
20120214693
2012-08-23

Methods for diagnosing breast cancer using MicroRNAs

#6980
20120214692
2012-08-23

Methods for diagnosing pancreatic cancer using miR-103-1, miR-103-2, miR-24-2 and miR-107

#6981
20120214691
2012-08-23

Methods for Diagnosing Breast Cancer Using miR-21, miR-125-1, miR-125b-2 and miR-145

#6982
20120214690
2012-08-23

Methods for Diagnosing Colon, Stomach, Prostate and Pancreas Cancer Using miR-223

#6983
20120214689
2012-08-23

Methods for Diagnosing Breast and Lung Cancer Using miR-210 and miR-213

#6984
20120214688
2012-08-23

Methods for diagnosing breast, colon, lung, pancreatic and prostate cancer using miR-21 and miR-17-5p

#6985
20120214240
2012-08-23

Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same

#6986
20120214234
2012-08-23

Induced pluripotent stem cells produced with a connexin inhibitor and a TGF-β signaling inhibitor

#6987
20120213788
2012-08-23

Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2

#6988
20120213768
2012-08-23

Diagnostic and Therapeutic Uses for B Cell Maturation Antigen

#6989
20120213746
2012-08-23

Method and compounds for generation of iPSCs

#6990
20120213744
2012-08-23

COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF

#6991
20120208863
2012-08-16

MODULATION OF GLUT4 GENE PROMOTER ACTIVITY BY AHNAK

#6992
20120208860
2012-08-16

Compositions and methods for inhibiting expression of factor VII gene

#6993
20120208278
2012-08-16

Innate immune suppression enables repeated delivery of long RNA molecules

#6994
20120208188
2012-08-16

Diagnostic and treatment for chronic and acute phase myeloid leukemia

#6995
20120207840
2012-08-16

Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer

#6996
20120207817
2012-08-16

Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer

#6997
20120207770
2012-08-16

ANTIPROLIFERATIVE AGENT

#6998
20120207753
2012-08-16

METHODS OF USING CD44 FUSION PROTEINS TO TREAT CANCER

#6999
20120207744
2012-08-16

REPROGRAMMING COMPOSITIONS AND METHODS OF USING THE SAME

#7000
20120202982
2012-08-09

Compositions and methods for therapy of macular degeneration

#7001
20120202875
2012-08-09

Method Of Treatment

#7002
20120202215
2012-08-09

MITOCHONDRIAL FUNCTION OF PROHIBITIN 2 (PHB2)

#7003
20120201872
2012-08-09

Liposomes comprising a calcium phosphate-containing precipitate

#7004
20120201838
2012-08-09

Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5

#7005
20120201837
2012-08-09

Use of eIF3m for the diagnosis and treatment of cancer

#7006
20120201832
2012-08-09

BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS

#7007
20120201794
2012-08-09

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

#7008
20120198573
2012-08-02

Agents that reduce neuronal overexcitation

#7009
20120196924
2012-08-02

Methods and products for expression of micro RNAs

#7010
20120196298
2012-08-02

Mitochondrial function of prohibitin 2 (PHB2)

#7011
20120195916
2012-08-02

METHOD OF TREATING CANCER BY INHIBITING TRIM59 EXPRESSION OR ACTIVITY

#7012
20120195890
2012-08-02

Oligonucleotides inhibiting cellular migration

#7013
20120192317
2012-07-26

Selecting and stabilizing dsRNA constructs

#7014
20120190727
2012-07-26

Method and means for treatment of osteoarthritis

#7015
20120190065
2012-07-26

COMBINATORIAL ENGINEERING

#7016
20120189555
2012-07-26

Methods and compositions for prevention or treatment of RSV infection

#7017
20120185971
2012-07-19

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#7018
20120184598
2012-07-19

Polynucleotides for multivalent RNA interference, compositions and methods of use thereof

#7019
20120184597
2012-07-19

Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

#7020
20120184595
2012-07-19

Compositions and methods for silencing apolipoprotein C-III expression

#7021
20120184463
2012-07-19

SiRNA targeting connective tissue growth factor (CTGF)

#7022
20120183955
2012-07-19

Construction of bifunctional short hairpin RNA

#7023
20120183602
2012-07-19

Lipid formulation

#7024
20120183581
2012-07-19

Lipid formulations for nucleic acid delivery

#7025
20120183553
2012-07-19

Treatment of immune disorders with Hom-1 inhibitors

#7026
20120183552
2012-07-19

KIDNEY DISEASE TARGETS AND USES THEREOF

#7027
20120183538
2012-07-19

SPARC ANTISENSE COMPOSITIONS AND USES THEREOF

#7028
20120183524
2012-07-19

MOLECULAR TARGETS FOR TREATMENT OF INFLAMMATION

#7029
20120180147
2012-07-12

MicroRNA-24

#7030
20120178796
2012-07-12

SPLICE VARIANTS

#7031
20120178795
2012-07-12

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

#7032
20120178794
2012-07-12

RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders

#7033
20120178791
2012-07-12

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)

#7034
20120177723
2012-07-12

siRNA phospholipid conjugate

#7035
20120177659
2012-07-12

Methods and compositions for treating and diagnosing diseases

#7036
20120174259
2012-07-05

Nucleic acid molecules that target the vacuolar atpase C subunit and confer resistance to coleopteran pests

#7037
20120172412
2012-07-05

In vivo polynucleotide delivery conjugates having enzyme sensitive linkages

#7038
20120172409
2012-07-05

METHODS AND KITS FOR LINKING POLYMORPHIC SEQUENCES TO EXPANDED REPEAT MUTATIONS

#7039
20120171721
2012-07-05

Host cell protein knock-out cells for production of therapeutic proteins

#7040
20120171686
2012-07-05

METHODS FOR THE IDENTIFICATION OF MICRORNA AND THEIR APPLICATIONS IN RESEARCH AND HUMAN HEALTH

#7041
20120171290
2012-07-05

HPV particles and uses thereof

#7042
20120171220
2012-07-05

Further use of protein kinase N beta

#7043
20120171170
2012-07-05

TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE

#7044
20120167253
2012-06-28

Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by RNAi

#7045
20120165399
2012-06-28

SnoRNAi-small nucleolar RNA degradation by RNA interference in trypanosomatids

#7046
20120165397
2012-06-28

Chemical modification of short small hairpin RNAs for inhibition of gene expression

#7047
20120165396
2012-06-28

Modulation of exportin 5 expression

#7048
20120165395
2012-06-28

Bruton's tyrosine kinase as anti-cancer drug target

#7049
20120165393
2012-06-28

Peptide-based in vivo siRNA delivery system

#7050
20120165391
2012-06-28

Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis

#7051
20120165390
2012-06-28

Compositions and Methods for Therapy and Diagnosis of Cancer

#7052
20120165387
2012-06-28

General composition framework for ligand-controlled RNA regulatory systems

#7053
20120164730
2012-06-28

COMPOSITIONS FOR SILENCING THE EXPRESSION OF VDAC1 AND USES THEREOF

#7054
20120164149
2012-06-28

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma

#7055
20120164112
2012-06-28

Expanding hematopoietic stem cells

#7056
20120159657
2012-06-21

Compositions and methods for inhibiting expression of RRM2 genes

#7057
20120157514
2012-06-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#7058
20120157512
2012-06-21

Preventing and Curing Beneficial Insect Diseases Via Plant Transcribed Molecules

#7059
20120157507
2012-06-21

USP47 inhibitors and methods to induce apoptosis

#7060
20120156770
2012-06-21

Human androgen receptor alternative splice variants

#7061
20120156223
2012-06-21

Method for inhibiting scavenger receptor-A and increasing immune Response to antigens

#7062
20120156208
2012-06-21

Therapeutic uses of inhibitors of RTP801

#7063
20120156180
2012-06-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES

#7064
20120151631
2012-06-14

Insect pest control method

#7065
20120150153
2012-06-14

Method and system for monitoring nutritional uptake as a function of microflora intestinal gas levels

#7066
20120150023
2012-06-14

MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY

#7067
20120149761
2012-06-14

NUCLEIC ACID MOLECULES AND USES THEREOF

#7068
20120149760
2012-06-14

Disabling autophagy as a treatment for lysosomal storage diseases

#7069
20120149754
2012-06-14

Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same

#7070
20120149649
2012-06-14

Short-chain cationic polyamino acid and use thereof

#7071
20120149069
2012-06-14

Methods and compositions for seamless cloning of nucleic acid molecules

#7072
20120148525
2012-06-14

Lepidopteran moth control using double-stranded RNA constructs

#7073
20120148524
2012-06-14

Formicidae (ant) control using double-stranded RNA constructs

#7074
20120148495
2012-06-14

Methods for treating nicotinic acetylcholine receptor associated diseases

#7075
20120144504
2012-06-07

CASPASE-8 AND SKIN DISEASE

#7076
20120142765
2012-06-07

Sphingosine-bound siRNA

#7077
20120142758
2012-06-07

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

#7078
20120142757
2012-06-07

RNAi Modulation of AHA and Therapeutic Uses Thereof

#7079
20120142754
2012-06-07

MODULATION OF TIMP1 AND TIMP2 EXPRESSION

#7080
20120142609
2012-06-07

NON HUMAN ANIMAL MODELS FOR INCREASED RETINAL VASCULAR PERMEABILITY

#7081
20120142608
2012-06-07

RCA LOCUS ANALYSIS TO ASSESS SUSCEPTIBILITY TO AMD AND MPGNII

#7082
20120142101
2012-06-07

Oligonucleotide end caps

#7083
20120142100
2012-06-07

Inhibitors of heat shock RNA

#7084
20120142011
2012-06-07

Modified siNA

#7085
20120142008
2012-06-07

METHODS FOR EVALUATING GASTROINTESTINAL ABSORPTION OF CHEMICALS

#7086
20120141590
2012-06-07

Technology for the Preparation of Microparticles

#7087
20120141461
2012-06-07

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING FIBROTIC DISORDERS

#7088
20120141456
2012-06-07

Use of DR6 and p75 antagonists to promote survival of cells of the nervous system

#7089
20120141378
2012-06-07

Methods for treating chronic kidney disease

#7090
20120141377
2012-06-07

Compositions and methods for treating cancer

#7091
20120136145
2012-05-31

Compositions and Methods for Inhibiting Expression of Eg5 Gene

#7092
20120136144
2012-05-31

SiRNA targeting catenin, beta-1 (CTNNB1)

#7093
20120136045
2012-05-31

Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation

#7094
20120136044
2012-05-31

Compositions And Methods Of Inhibiting NADPH Oxidase Expression

#7095
20120136041
2012-05-31

Treating ocular diseases using peroxisome proliferator—activated receptor delta antagonists

#7096
20120136040
2012-05-31

HYBRID INTERFERING RNA

#7097
20120136039
2012-05-31

Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease

#7098
20120135892
2012-05-31

siRNA targeting spleen tyrosine kinase

#7099
20120135408
2012-05-31

UNC-45A splice variants based cancer diagnostics and therapeutics

#7100
20120129918
2012-05-24

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#7101
20120129917
2012-05-24

Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin

#7102
20120129916
2012-05-24

Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof

#7103
20120129915
2012-05-24

Organic compositions to treat HSF1-related diseases

#7104
20120129914
2012-05-24

Organic compositions to treat HSF1-related diseases

#7105
20120129913
2012-05-24

dsRNA for treating viral infection

#7106
20120129910
2012-05-24

Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

#7107
20120129788
2012-05-24

Phosphodiesterase 4D7 as marker for malignant, hormone-sensitive prostate cancer

#7108
20120129782
2012-05-24

Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders

#7109
20120129218
2012-05-24

Cofilin knockdown host cells and uses thereof

#7110
20120129161
2012-05-24

Methods for modulating embryonic stem cell differentiation

#7111
20120128760
2012-05-24

Lipid compositions

#7112
20120128756
2012-05-24

Skin permeating and cell entering (SPACE) peptides and methods of use thereof

#7113
20120128679
2012-05-24

Human antibodies to the human glucagon receptor and methods of use thereof

#7114
20120128677
2012-05-24

Pancreatic cancer targets and uses thereof

#7115
20120128661
2012-05-24

POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER

#7116
20120124683
2012-05-17

Delivery method

#7117
20120122962
2012-05-17

Modified Small Interfering RNA Molecules and Methods of Use

#7118
20120122961
2012-05-17

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#7119
20120122960
2012-05-17

Organic compositions to treat Beta-ENaC-related diseases

#7120
20120122958
2012-05-17

Transcriptional repression leading to Parkinson's disease

#7121
20120122800
2012-05-17

Long-Acting DNA Dendrimers and Methods Thereof

#7122
20120122770
2012-05-17

Cell Cycle Arrest and Apoptosis

#7123
20120122217
2012-05-17

METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS

#7124
20120122216
2012-05-17

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#7125
20120122111
2012-05-17

RNA sequence-specific mediators of RNA interference

#7126
20120121689
2012-05-17

SMALL INTERFERING RNA DELIVERY

#7127
20120121610
2012-05-17

THERAPEUTIC AGENT AND ASSAY

#7128
20120121608
2012-05-17

Use of SAM68 for modulating signaling through the TNF receptor

#7129
20120121579
2012-05-17

TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE

#7130
20120121575
2012-05-17

Prohibitin as target for cancer therapy

#7131
20120121559
2012-05-17

Treatment and prevention of pathological conditions using iduna related techniques and compositions

#7132
20120121515
2012-05-17

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

#7133
20120116360
2012-05-10

Treatment of neurological disorders

#7134
20120115935
2012-05-10

ANTI-CANCER AGENT, METHOD FOR INDUCING APOPTOSIS OF CANCER CELLS, AND METHOD FOR SCREENING FOR ANTI-CANCER AGENT

#7135
20120115934
2012-05-10

Organic compositions to treat beta-ENaC-related diseases

#7136
20120115933
2012-05-10

Organic compositions to treat Beta-ENaC-related diseases

#7137
20120115931
2012-05-10

Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

#7138
20120115923
2012-05-10

Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment

#7139
20120114759
2012-05-10

PEPTIDE/PARTICLE DELIVERY SYSTEMS

#7140
20120114710
2012-05-10

CARBON NANOTUBES COMPLEXED WITH MULTIPLE BIOACTIVE AGENTS AND METHODS RELATED THERETO

#7141
20120114618
2012-05-10

Mesenchymal Stem Cells Producing Inhibitory RNA for Disease Modification

#7142
20120114607
2012-05-10

Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules

#7143
20120108803
2012-05-03

siRNA conjugate and preparation method thereof

#7144
20120108649
2012-05-03

Methods and compositions to protect aquatic invertebrates from disease

#7145
20120108648
2012-05-03

Mitochondrial function-improving agent

#7146
20120108647
2012-05-03

THERAPEUTIC USES OF INHIBITORS OF RTP801L

#7147
20120108646
2012-05-03

RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof

#7148
20120108497
2012-05-03

Compositions for conferring tolerance to viral disease in social insects, and the use thereof

#7149
20120107897
2012-05-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

#7150
20120107389
2012-05-03

AMPHOTERIC LIPOSOMAL COMPOSITIONS FOR CELLULAR DELIVERY OF SMALL RNA MOLECULES FOR USE IN RNA INTERFERENCE

#7151
20120107355
2012-05-03

METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS

#7152
20120107313
2012-05-03

Mammalian receptor proteins DCRS5; methods of treatment

#7153
20120107297
2012-05-03

Method for therapeutic angiogenesis

#7154
20120107264
2012-05-03

NUCLEIC ACID DELIVERY COMPOUNDS

#7155
20120101045
2012-04-26

Transducible delivery of nucleic acids using modified dsRNA binding domains

#7156
20120100160
2012-04-26

Methods for Inducing Mixed Chimerism

#7157
20120100144
2012-04-26

Biomarker and Treatment for Cancer

#7158
20120095200
2012-04-19

COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY NUCLEIC ACID CONTAINING A DICER SUBSTRATE AND A RECEPTOR BINDING REGION

#7159
20120095082
2012-04-19

Use of interfering rna for treating an hiv infection

#7160
20120095081
2012-04-19

Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

#7161
20120095080
2012-04-19

METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULES

#7162
20120095076
2012-04-19

Compositions and methods for inhibiting expression of huntingtin gene

#7163
20120095075
2012-04-19

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

#7164
20120095074
2012-04-19

Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes

#7165
20120094374
2012-04-19

MicroRNAs and uses thereof

#7166
20120094329
2012-04-19

Increasing protein production by increasing ABC50 expression or activity

#7167
20120093916
2012-04-19

Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA

#7168
20120093913
2012-04-19

Inhibition of SYK kinase expression

#7169
20120093828
2012-04-19

VACCINE COMPOSITIONS AND METHODS FOR TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES

#7170
20120093773
2012-04-19

Compositions for bacterial mediated gene silencing and methods of using same

#7171
20120088842
2012-04-12

METHODS FOR OPTIMIZING ELECTROPORATION

#7172
20120088817
2012-04-12

Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene

#7173
20120088727
2012-04-12

Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesis

#7174
20120088298
2012-04-12

IKKALPHA AND IKKBETA SPECIFIC INHIBITORS

#7175
20120087973
2012-04-12

siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES

#7176
20120087914
2012-04-12

INHIBITION OF TRIM62 ACTIVITY REDUCES CANCER CELL PROLIFERATION

#7177
20120084872
2012-04-05

Methods for producing microRNAs

#7178
20120083037
2012-04-05

Non-Viral Transfection Agent

#7179
20120077864
2012-03-29

RNAI-MEDIATED INHIBITION OF GREMLIN FOR TREATMENT OF IOP-RELATED CONDITIONS

#7180
20120077862
2012-03-29

Antisense modulation of PTP1B expression

#7181
20120077753
2012-03-29

JNK INHIBITORS FOR USE IN TREATING SPINAL MUSCULAR ATROPHY

#7182
20120077750
2012-03-29

Use of a growth-stimulating protein

#7183
20120077698
2012-03-29

High Throughput Assay for Cancer Cell Growth Inhibition

#7184
20120077276
2012-03-29

Methods of determining potency of chemically-synthesized oligonucleotides

#7185
20120076823
2012-03-29

Vector

#7186
20120076788
2012-03-29

C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER

#7187
20120076763
2012-03-29

Combination anti-HIV vectors, targeting vectors, and methods of use

#7188
20120076735
2012-03-29

Nanoparticles for Extravascular Administration

#7189
20120073018
2012-03-22

curcin genes, tissue-specific promoters and generation of curcin-deficient transgenic plants

#7190
20120071641
2012-03-22

Nucleic acid chemical modifications

#7191
20120071417
2012-03-22

Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors

#7192
20120070892
2012-03-22

DNA virus MicroRNA and methods for inhibiting same

#7193
20120070486
2012-03-22

METHODS AND COMPOSITIONS RELATED TO PREFOLDIN AND ITS REGULATION

#7194
20120070442
2012-03-22

METHODS AND COMPOSITIONS FOR TREATING CANCER

#7195
20120066777
2012-03-15

Test agent for visceral obesity and use thereof

#7196
20120065250
2012-03-15

SiRNA targeting apolipoprotein B (APOB)

#7197
20120065248
2012-03-15

Methods and compositions involving miRNA and miRNA inhibitor molecules

#7198
20120065247
2012-03-15

MODULATING IRES-MEDIATED TRANSLATION

#7199
20120065246
2012-03-15

RNA MOLECULES AND THERAPEUTIC USES THEREOF

#7200
20120065243
2012-03-15

RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality